The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease

European Respiratory Journal

Volumn 23, Issue 2, 2004, Pages 219-223

  Ogus, A Candan ^a,c   Yoldas, B ^a   Ozdemir, T ^a   Uguz, A ^a   Olcen, S ^b   Kaser, I ^a   Coskun, M ^a   Cilli, A ^a   Yegin, O ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b State Tuberculosis Control Centre   (Turkey)

^c NONE   (Turkey)

Author keywords

Immunity; Polymorphism; Toll like receptor; Tuberculosis

Indexed keywords

ADENINE; ARGININE; GLUTAMINE; TOLL LIKE RECEPTOR 2;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNE RESPONSE; KIDNEY TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PLEURISY;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ARGININE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMINE; HETEROZYGOTE DETECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOGENETICS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY; TURKEY;

EID: 1042269515     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00061703     Document Type: Article

References (32)

1. Rosman MD, Oner Eyüpoǧlu AF. Clinical presentation and treatment of tuberculosis. In: Fishman AP, ed. Fishman's Pulmonary Diseases and Disorders. 3rd Edn. New York, NY, USA, McGraw-Hill, 1998; pp. 2483-2501.
2. Fraser RS, Muller NL, Colman N, Pare PD. eds. Mycobacteria. In: Fraser and Pare's Diagnosis of Diseases of the Chest. 4th Edn. Philadelphia, PA, USA, W.B. Saunders Company, 1999; pp. 798-873.
3. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941-1949.
4. Jouanguy E, Lamhamedi S, Emile JF, et al. Interferon-γ-receptor deficiency in an infant with fatal bacilli Calmette-Guérin infection. N Engl J Med 1996; 335: 1956-1959.
5. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
6. Guide SV, Holland SM. Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect Dis Clin North Am 2002; 16: 163-186.
7. Dupuis S, Dargemont C, Fieschi C, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001; 293: 300-303.
8. Crevel R, Ottenhoff THM, Meer WM. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002; 15: 294-309.
9. Means TK, Jones BW, Schromm AB, et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001; 166: 4074-4082.
10. Reiling N, Hölscher C, Fehrenbach A, et al. Cutting edge: Toll-like receptor (TLR) 2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169: 3480-3484.
11. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001; 167: 987-994.
12. Tsuji S, Matsumoto M, Takeuchi O, et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of Toll-like receptors. Infect Immun 2000; 68: 6883-6890.
13. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 3920-3927.
14. Noss EH, Pai RK, Sellati TJ, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001; 167: 910-918.
15. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97: 13766-13771.
16. Supajatura V, Ushio H, Nakao A, et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109: 1351-1359.
17. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398-6401.
18. Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001; 291: 1544-1547.
19. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-933.
20. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503-2516.
21. Weiss ST, Martinez F. Bioinformatics Tools. Exact Hardy-Weinberg. http://innateimmunity.net/IIPGA2/Bioinformatics/Date updated: 4 August 2003. Date accessed: August 2003.
22. Kang TJ, Chae GT. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001; 31: 53-58.
23. Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signalling. J Immunol 2003; 170: 3451-3454.
24. Frucht DM, Holland SM. Defective monocyte costimulation for IFN-γ production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J Immunol 1996; 157: 411-416.
25. de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998; 280: 1435-1438.
26. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101: 2364-2369.
27. Bellamy R, Ruwende C, Corrah T, McAdam K, Whittle HC, Hill AVS. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
28. Awomoyi AA, Marchant A, Howson JMM, McAdam KPWJ, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SCL11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002; 186: 1808-1814.
29. Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724.
30. Ozkara S, Kilicaslan Z, Ozturk F, et al. Bolge verileriyle Turkiye'de tuberkuloz. Toraks Dergisi 2002; 3: 178-187.
31. Cuhadaroglu C, Erelel M, Tabak L, Kilicaslan Z. Increased risk of tuberculosis in health care workers: a retrospective survey at a teaching hospital in Istanbul, Turkey. BMC Infect Dis 2002; 2: 14. http://www.biomedcentral.com/1471-2334/2114.
32. Guz K, Dedeoglu N, Luleci G. The frequency and medical effects of consanguineous marriages in Antalya, Turkey. Hereditas 1989; 111: 78-83.